Edgar B. Cale's most recent trade in Passage Bio Inc was a trade of 278,386 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Passage Bio Inc | Edgar B. Cale | GC & CORPORATE SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 278,386 | 278,386 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | Edgar B. Cale | GC & CORPORATE SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | Edgar B. Cale | GC & CORPORATE SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 203,000 | 203,000 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | B. Edgar Cale | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 50,000 | 61,808 (0%) | 0% | - | Common Stock | |
| Passage Bio Inc | Edgar Cale B. | GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 50,000 | 0 | - | - | Restricted Stock Unit | |
| Passage Bio Inc | B. Edgar Cale | GC & Corporate Secretary | Sale of securities on an exchange or to another person at price $ 0.91 per share. | 31 Dec 2023 | 15,813 | 45,995 (0%) | 0% | 0.9 | 14,390 | Common Stock |
| Passage Bio Inc | Edgar B. Cale | GC & Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | Edgar B. Cale | GC & Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 50,000 | 50,000 | - | - | Restricted Stock Unit | |
| Passage Bio Inc | Edgar B. Cale | Interim CEO, GC & Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 106,000 | 106,000 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | Edgar B. Cale | Interim CEO, GC & Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Passage Bio Inc | Edgar B. Cale | GC and Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 106,000 | 106,000 | - | - | Stock Option (right to buy) | |
| Passage Bio Inc | Edgar B. Cale | GC and Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 170,997 | 170,997 | - | - | Stock Option (right to buy) |